Panel discussion

A strong scientific case is not enough. Maximizing commercial potential starts early and needs to be an integral part of successful development. Yet, many biotechs start (too) late. Explore strategies for efficient and effective development, enhancing asset value by integrating payer-relevant input. Gain insights from industry leaders and healthcare payers as they discuss ways to refine your approach and demonstrate value that convinces payers and investors.